Artículos de revistas sobre el tema "Melanoma Antigen Genes (MAGE)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Melanoma Antigen Genes (MAGE)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas y T. Boon. "A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma." Journal of Experimental Medicine 182, n.º 3 (1 de septiembre de 1995): 689–98. http://dx.doi.org/10.1084/jem.182.3.689.
Texto completoUlloa-Montoya, Fernando, Jamila Louahed, Benjamin Dizier, Olivier Gruselle, Bart Spiessens, Frédéric F. Lehmann, Stefan Suciu et al. "Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy". Journal of Clinical Oncology 31, n.º 19 (1 de julio de 2013): 2388–95. http://dx.doi.org/10.1200/jco.2012.44.3762.
Texto completoHuang, Lan-Qing, Francis Brasseur, Alfonso Serrano, Etienne De Plaen, Pierre van der Bruggen, Thierry Boon y Aline Van Pel. "Cytolytic T Lymphocytes Recognize an Antigen Encoded by MAGE-A10 on a Human Melanoma". Journal of Immunology 162, n.º 11 (1 de junio de 1999): 6849–54. http://dx.doi.org/10.4049/jimmunol.162.11.6849.
Texto completoMiyashiro, Isao, Christine Kuo, Kelly Huynh, Aritoshi Iida, Donald Morton, Anton Bilchik, Armando Giuliano y Dave S. B. Hoon. "Molecular Strategy for Detecting Metastatic Cancers with Use of Multiple Tumor-specific MAGE-A Genes". Clinical Chemistry 47, n.º 3 (1 de marzo de 2001): 505–12. http://dx.doi.org/10.1093/clinchem/47.3.505.
Texto completoBaurain, J., M. Stas, B. Neyns, G. Schuler, T. Velu, K. Thielemans, N. Van Baren, T. Dorval, M. Marchand y P. Coulie. "Comparing immunogenicities of tumor-specific antigens administered as therapeutic vaccines in metastatic melanoma patients". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 3003. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.3003.
Texto completoFlorke Gee, Rebecca R., Helen Chen, Anna K. Lee, Christina A. Daly, Benjamin A. Wilander, Klementina Fon Tacer y Patrick Ryan Potts. "Emerging roles of the MAGE protein family in stress response pathways". Journal of Biological Chemistry 295, n.º 47 (13 de septiembre de 2020): 16121–55. http://dx.doi.org/10.1074/jbc.rev120.008029.
Texto completoPark, Myeng Sun, Jong Wook Park, Chang Ho Jeon, Kang Dae Lee y Hee Kyung Chang. "Expression of Melanoma Antigen-Encoding Genes (MAGE) by Common Primers for MAGE-A1 to -A6 in Colorectal Carcinomas Among Koreans". Journal of Korean Medical Science 17, n.º 4 (2002): 497. http://dx.doi.org/10.3346/jkms.2002.17.4.497.
Texto completoLin, Yuquan, Ti Wen, Xianyi Meng, Zhenzhou Wu, Liqing Zhao, Puyue Wang, Zhangyong Hong y Zhinan Yin. "The mouse Mageb18 gene encodes a ubiquitously expressed type I MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cells". Biochemical Journal 443, n.º 3 (16 de abril de 2012): 779–88. http://dx.doi.org/10.1042/bj20112054.
Texto completoRies, Jutta, Nur Mollaoglu, Takeshi Toyoshima, Eleftherios Vairaktaris, Friedrich W. Neukam, Sabine Ponader y Emeka Nkenke. "A novel Multiple-Marker Method for the Early Diagnosis of Oral Squamous Cell Carcinoma". Disease Markers 27, n.º 2 (2009): 75–84. http://dx.doi.org/10.1155/2009/510124.
Texto completoFon Tacer, Klementina, Marhiah C. Montoya, Melissa J. Oatley, Tessa Lord, Jon M. Oatley, Jonathon Klein, Ramya Ravichandran et al. "MAGE cancer-testis antigens protect the mammalian germline under environmental stress". Science Advances 5, n.º 5 (mayo de 2019): eaav4832. http://dx.doi.org/10.1126/sciadv.aav4832.
Texto completoKasuga, Chinatsu, Yukiko Nakahara, Shigeo Ueda, Cynthia Hawkins, Michael D. Taylor, Christian A. Smith y James T. Rutka. "Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy". Journal of Neurosurgery: Pediatrics 1, n.º 4 (abril de 2008): 305–13. http://dx.doi.org/10.3171/ped/2008/1/4/305.
Texto completoWu, Yunyan, Meixiang Sang, Fei Liu, Jiandong Zhang, Weijing Li, Zhenhua Li, Lina Gu, Yang Zheng, Juan Li y Baoen Shan. "Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma". Carcinogenesis 41, n.º 7 (12 de junio de 2020): 894–903. http://dx.doi.org/10.1093/carcin/bgaa057.
Texto completoValiño-Rivas, Lara, Leticia Cuarental, Mateo Agustin, Holger Husi, Pablo Cannata-Ortiz, Ana B. Sanz, Harald Mischak, Alberto Ortiz y Maria Dolores Sanchez-Niño. "MAGE genes in the kidney: identification of MAGED2 as upregulated during kidney injury and in stressed tubular cells". Nephrology Dialysis Transplantation 34, n.º 9 (11 de diciembre de 2018): 1498–507. http://dx.doi.org/10.1093/ndt/gfy367.
Texto completoOh, Chaeun, Hwa-Ryeon Kim, Sumin Oh, Je Yeong Ko, Yesol Kim, Keunsoo Kang, Young Yang et al. "Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness". Cancers 13, n.º 13 (25 de junio de 2021): 3176. http://dx.doi.org/10.3390/cancers13133176.
Texto completoFaiena, Izak, Samuel Aaron Funt, Stephanie H. Astrow, Tanya B. Dorff, Sabina Adhikary, Tristan Gorgan, Jonathan E. Rosenberg, David Elashoff, Allan J. Pantuck y Alexandra Drakaki. "Differential expression of melanoma-associated antigen A3/6 and associated immune molecules prior to and post treatment with immune checkpoint inhibitors (ICI) in patients with mUC." Journal of Clinical Oncology 38, n.º 6_suppl (20 de febrero de 2020): 433. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.433.
Texto completoBozkurt, Süreyya, Filiz Yarimcan, Hüseyin Ayhan, Hacer Kotan, Hüma Tuğçe Sezgin, Elif Çınar, Ceren Aynacı, Remzi Okan Akar y Veysel Sabri Hançer. "Investigation of PTGS2, MAGE-A3, CALR, KRT19 and TMPRSS4 expressions in HCT116 colon cancer and PC3 prostate cancer cell lines". Genetics & Applications 4, n.º 2 (24 de diciembre de 2020): 37. http://dx.doi.org/10.31383/ga.vol4iss2pp37-42.
Texto completoMiller, AR, WH McBride, SM Dubinett, GJ Dougherty, JD Thacker, H. Shau, DB Kohn, RC Moen, MJ Walker y R. Chiu. "Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2". Blood 82, n.º 12 (15 de diciembre de 1993): 3686–94. http://dx.doi.org/10.1182/blood.v82.12.3686.3686.
Texto completoMiller, AR, WH McBride, SM Dubinett, GJ Dougherty, JD Thacker, H. Shau, DB Kohn, RC Moen, MJ Walker y R. Chiu. "Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2". Blood 82, n.º 12 (15 de diciembre de 1993): 3686–94. http://dx.doi.org/10.1182/blood.v82.12.3686.bloodjournal82123686.
Texto completoBhat, Smitha S., Shreya Das Mahapatra, Sindhu R, Sarana Rose Sommano y Shashanka K. Prasad. "Virtual Screening and Quantitative Structure–Activity Relationship of Moringa oleifera with Melanoma Antigen A (MAGE-A) Genes against the Therapeutics of Non-Small Cell Lung Cancers (NSCLCs)". Cancers 14, n.º 20 (15 de octubre de 2022): 5052. http://dx.doi.org/10.3390/cancers14205052.
Texto completoLu, Yong-Chen, Linda L. Parker, Tangying Lu, Zhili Zheng, Mary Ann Toomey, Donald E. White, Xin Yao et al. "Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3". Journal of Clinical Oncology 35, n.º 29 (10 de octubre de 2017): 3322–29. http://dx.doi.org/10.1200/jco.2017.74.5463.
Texto completoMollaoglu, Nur, Eleftherios Vairaktaris, Emeka Nkenke, Friedrich W. Neukam y Jutta Ries. "Expression of MAGE-A12 in Oral Squamous Cell Carcinoma". Disease Markers 24, n.º 1 (2008): 27–32. http://dx.doi.org/10.1155/2008/359840.
Texto completoTakeuchi, Hiroya, Donald L. Morton, Christine Kuo, Roderick R. Turner, David Elashoff, Robert Elashoff, Bret Taback, Akihide Fujimoto y Dave S. B. Hoon. "Prognostic Significance of Molecular Upstaging of Paraffin-Embedded Sentinel Lymph Nodes in Melanoma Patients". Journal of Clinical Oncology 22, n.º 13 (1 de julio de 2004): 2671–80. http://dx.doi.org/10.1200/jco.2004.12.009.
Texto completoMikhaylova, I. N., H. M. Treshalina, I. A. Utyashev, M. V. Kiselevsky, A. A. Lushnikova y I. Zh Shubina. "ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA". Siberian journal of oncology 20, n.º 3 (29 de junio de 2021): 98–106. http://dx.doi.org/10.21294/1814-4861-2021-20-2-98-106.
Texto completoTüting, Thomas, Cara C. Wilson, Dina M. Martin, Yvette L. Kasamon, Jennifer Rowles, Debora I. Ma, Craig L. Slingluff et al. "Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-α". Journal of Immunology 160, n.º 3 (1 de febrero de 1998): 1139–47. http://dx.doi.org/10.4049/jimmunol.160.3.1139.
Texto completoReu, Frederic J., Soo In Bae, Leonid Cherkassky, Douglas W. Leaman, Daniel Lindner, Normand Beaulieu, A. Robert MacLeod y Ernest C. Borden. "Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation". Journal of Clinical Oncology 24, n.º 23 (10 de agosto de 2006): 3771–79. http://dx.doi.org/10.1200/jco.2005.03.4074.
Texto completoCai, Pan, Yan Lu, Zhifeng Yin, Xiuhui Wang, Xiaoxiao Zhou y Zhuokai Li. "Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases". BioMed Research International 2021 (6 de julio de 2021): 1–9. http://dx.doi.org/10.1155/2021/6885897.
Texto completoNardiello, Tricia, Anna Mei, Michael Mangone y Hearn J. Cho. "CT7 (MAGE-C1) Promotes Survival and Interacts with STAT1 and PIASy in Multiple Myeloma Cells". Blood 118, n.º 21 (18 de noviembre de 2011): 1807. http://dx.doi.org/10.1182/blood.v118.21.1807.1807.
Texto completoThompson, Jeffrey C., Christiana Davis, Charuhas Deshpande, Wei-Ting Hwang, Seth Jeffries, Alexander Huang, Tara C. Mitchell, Corey J. Langer y Steven M. Albelda. "Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma". Journal for ImmunoTherapy of Cancer 8, n.º 2 (octubre de 2020): e000974. http://dx.doi.org/10.1136/jitc-2020-000974.
Texto completoCho, Hearn Jay, Anna Huo-Chang Mei, Kaity Tung, Jessie Han, Deepak Perumal, Jonathan J. Keats, Daniel Auclair et al. "MAGE-A3 Promotes Chemotherapy Resistance and Proliferation in Multiple Myeloma through Regulation of BIM and p21Cip1". Blood 132, Supplement 1 (29 de noviembre de 2018): 4464. http://dx.doi.org/10.1182/blood-2018-99-118692.
Texto completoCho, Hearn Jay, Anna Mei, Jami Fukui, Kaity Tung, Violetta V. Leshchenko, Alessandro Lagana, Manishkumar Patel et al. "MAGE-a Mediate Resistance to Chemotherapy in Multiple Myeloma through Regulation of Bcl-2 Proteins". Blood 128, n.º 22 (2 de diciembre de 2016): 3277. http://dx.doi.org/10.1182/blood.v128.22.3277.3277.
Texto completoAdamik, Juraj, Deena Maurer, Paul Munson, Alexis Combes, Philippe Pierre, Matthew Krummel, Rafael Argüello y Lisa Butterfield. "299 Immuno-metabolic signatures of dendritic cells associate with T-cell responses in melanoma patients". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A326. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0299.
Texto completoChang, Yao-Jen, Zhifu Kang, Jiayuan Bei, Shu-Jen Chou, Mei-Yeh Jade Lu, Yu-Lun Su, Sheng-Wei Lin, Hsin-Hui Wang, Steven Lin y Ching-Jin Chang. "Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits". International Journal of Molecular Sciences 23, n.º 12 (20 de junio de 2022): 6839. http://dx.doi.org/10.3390/ijms23126839.
Texto completoBräunig, Sandro, Dimitra Zacharaki, Hongzhe Li, Hooi Ching Lim, Stefan Lang, Thoas Fioretos y Stefan Scheding. "Transcriptome Alterations of Isolated Primary Bone Marrow Endothelial Cells Provide Insigt to MGUS and Multiple Myeloma Pathobiology". Blood 134, Supplement_1 (13 de noviembre de 2019): 4373. http://dx.doi.org/10.1182/blood-2019-128024.
Texto completoMeneveau, Max, Pankaj Kumar, Kevin Lynch, Karlyn Pollack y Craig Slingluff. "611 RNA-sequencing reveals a unique immune transcriptional landscape in the vaccine sites of patients with circulating T-cell responses to cancer immunization". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A646—A647. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0611.
Texto completoShin, Gyu-Tae, Ji Eun Park y Min-Jeong Lee. "MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis". PLOS ONE 16, n.º 11 (17 de noviembre de 2021): e0260135. http://dx.doi.org/10.1371/journal.pone.0260135.
Texto completoHoon, D. S., D. Yuzuki, M. Hayashida y D. L. Morton. "Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen." Journal of Immunology 154, n.º 2 (15 de enero de 1995): 730–37. http://dx.doi.org/10.4049/jimmunol.154.2.730.
Texto completoHoward, Scott C., Ansu Kumar, Michael Castro, Himanshu Grover, Subrat Mohapatra, Shweta Kapoor, Anuj Tyagi et al. "Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Identifies Immune Modulation As a Key Pathway for Predicting Azacitidine (AZA) Response in Myelodysplastic Syndromes (MDS)". Blood 138, Supplement 1 (5 de noviembre de 2021): 3690. http://dx.doi.org/10.1182/blood-2021-153539.
Texto completoAsai, Takashi, Yan Liu, Silvana Di Giandomenico, Anthony Deblasio, Silvia Menendez, Jack Antipin, Boris Reva, Rachel Wevrick y Stephen D. Nimer. "Necdin Regulates Hematopoietic Stem Cell Quiescence and Sensitivity to Genotoxic Stress." Blood 114, n.º 22 (20 de noviembre de 2009): 379. http://dx.doi.org/10.1182/blood.v114.22.379.379.
Texto completoZewdu, Eden B., Rachel M. Gonzalez, Yan Ma, Derek Ling, Xiaomin Hu, Qi Ren, Ranran Zhang et al. "Abstract 2803: A renewable IHC control tool CytoSections࣪ for defining MAGEA3, MAGEA4, and MAGEA9 antibody specificity". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2803. http://dx.doi.org/10.1158/1538-7445.am2022-2803.
Texto completoGaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur y T. Boon. "Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes." Journal of Experimental Medicine 179, n.º 3 (1 de marzo de 1994): 921–30. http://dx.doi.org/10.1084/jem.179.3.921.
Texto completoDePietro, Paul, Mary Nesline, Yong Hee Lee, RJ Seager, Erik Van Roey, Shuang Gao, Vincent Giamo et al. "77 Prevalence of secondary immunotherapeutic targets in the absence of established immune biomarkers in solid tumors". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (noviembre de 2021): A86. http://dx.doi.org/10.1136/jitc-2021-sitc2021.077.
Texto completoCheng, Sonia, Wei Liu, Moises Mercado, Shereen Ezzat y Sylvia L. Asa. "Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer". Endocrine-Related Cancer 16, n.º 2 (junio de 2009): 455–66. http://dx.doi.org/10.1677/erc-09-0002.
Texto completoSchuler-Thurner, Beatrice, Erwin S. Schultz, Thomas G. Berger, Georg Weinlich, Susanne Ebner, Petra Woerl, Armin Bender et al. "Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells". Journal of Experimental Medicine 195, n.º 10 (13 de mayo de 2002): 1279–88. http://dx.doi.org/10.1084/jem.20012100.
Texto completoManici, Simona, Tiziana Sturniolo, Maria Adele Imro, Juergen Hammer, Francesco Sinigaglia, Christoph Noppen, Giulio Spagnoli et al. "Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11". Journal of Experimental Medicine 189, n.º 5 (1 de marzo de 1999): 871–76. http://dx.doi.org/10.1084/jem.189.5.871.
Texto completoValmori, Danila, Uzi Gileadi, Catherine Servis, P. Rod Dunbar, Jean-Charles Cerottini, Pedro Romero, Vincenzo Cerundolo y Frédéric Lévy. "Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3". Journal of Experimental Medicine 189, n.º 6 (15 de marzo de 1999): 895–906. http://dx.doi.org/10.1084/jem.189.6.895.
Texto completoTraversari, C., P. van der Bruggen, I. F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, E. De Plaen, A. Amar-Costesec y T. Boon. "A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E." Journal of Experimental Medicine 176, n.º 5 (1 de noviembre de 1992): 1453–57. http://dx.doi.org/10.1084/jem.176.5.1453.
Texto completoBolli, Martin, Thomas Kocher, Michel Adamina, Ulrich Guller, Peter Dalquen, Philippe Haas, Martina Mirlacher et al. "Tissue Microarray Evaluation of Melanoma Antigen E (MAGE) Tumor-Associated Antigen Expression". Annals of Surgery 236, n.º 6 (diciembre de 2002): 785–93. http://dx.doi.org/10.1097/00000658-200212000-00011.
Texto completoLendvai, Nikoletta, Sacha Gnjatic, Erika Ritter, Yao-Tseng Chen, Christina Coughlin, Robert H. Vonderheide, Ruben Niesvizky et al. "Host Immune Responses Against CT Antigens in Multiple Myeloma Patients." Blood 108, n.º 11 (16 de noviembre de 2006): 3492. http://dx.doi.org/10.1182/blood.v108.11.3492.3492.
Texto completoSrisawat, Wanwisa, Boondarika Nambooppha, Kidsadagon Pringproa, Atigan Thongtharb, Worapat Prachasilchai y Nattawooti Sthitmatee. "A Preliminary Study of the Cross-Reactivity of Canine MAGE-A with Hominid Monoclonal Antibody 6C1 in Canine Mammary Gland Tumors: An Attractive Target for Cancer Diagnostic, Prognostic and Immunotherapeutic Development in Dogs". Veterinary Sciences 7, n.º 3 (10 de agosto de 2020): 109. http://dx.doi.org/10.3390/vetsci7030109.
Texto completoKanda, Mitsuro, Hisaharu Oya, Soki Hibino, Hideki Takami, Dai Shimizu, Masahiko Koike, Shuji Nomoto et al. "Overexpression of melanoma-associated antigen D4 as an independent prognostic factor in squamous cell carcinoma of the esophagus." Journal of Clinical Oncology 32, n.º 3_suppl (20 de enero de 2014): 71. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.71.
Texto completo